Breast cancer vaccine shows promise in small clinical trial

A breast cancer vaccine developed at the School of Medicine is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.

The human eye can see ‘invisible’ infrared light

Science textbooks say we can’t see infrared light. Like X-rays and radio waves, infrared light waves are longer than the light waves in the visual spectrum. But an international team of researchers co-led by Frans Vinberg, PhD, (left) and Vladimir J. Kefalov, PhD, has found that under certain conditions, the retina can sense infrared light after all.

Vaccines may make war on cancer personal

In the near future, physicians may treat some cancer patients with personalized vaccines that spur their immune systems to attack malignant tumors. New research led by scientists at the School of Medicine including senior author Robert Schreiber, PhD, has brought the approach one step closer to reality.

Three WUSTL faculty named AAAS fellows

Three faculty members at Washington University in St. Louis have been named fellows of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society. They are Mary C. Dinauer, MD, PhD, David M. Holtzman, MD, and Robert G. Kranz, PhD.
View More Stories